期刊文献+

降糖益肾汤治疗早期糖尿病肾病40例疗效观察 被引量:21

Clinical Effect of Jiangtang Yishen Decoction in Treating Early Stage of Diabetic Nephropathy
下载PDF
导出
摘要 目的:观察降糖益肾汤治疗早期糖尿病肾病的临床疗效。方法:将80例糖尿病肾病患者,随机分为对照组和治疗组,2组均在常规治疗基础上,对照组40例给予阿魏酸哌嗪片(成都亨达药业有限公司)国药准字H51023368,200 mg 3次/d。治疗组服用降糖益肾汤,1剂/d,水煎取汁300 m L分早晚2次温服。2组均治疗3个月。结果:与治疗前比较,治疗组治疗后尿微量白蛋白明显下降,临床症状有所改善,总有效率90%,对照组治疗后总有效率52.5%,因此治疗组明显优于对照组两组比较具有统计学意义(P<0.05)。结论:降糖益肾汤治疗早期糖尿病肾病效果良好,值得临床进一步研究和推广应用。 Objective: To investigate the clinical effect of Jiangtang Yishen Decoction in treating early stage of diabetic nephropathy. Methods: 80 patients with diabetic nephropathy were randomly divided into the treatment group and the control group,40 cases in each group. The control group was given conventional therapy,while the treatment group was given Jiangtang Yishen Decoction more. Both groups were treated for 3 months. Results: Compared with prior treatment,the level of urine microalbumin in the treatment group decreased significantly,clinical symptoms improved a lot,and the total effective rate was 90%,while the level of urine microalbumin in the control group decreased insignificantly,and the total effective rate was 52. 5%. The treatment effect in both groups had a significant difference( P〈0. 05). Conclusion: The clinical effect of Jiangtang Yishen Decoction has superior obvious effect for early diabetic nephropathy to the conventional treatment alone.
作者 付旭彦
出处 《成都中医药大学学报》 2016年第1期84-86,共3页 Journal of Chengdu University of Traditional Chinese Medicine
关键词 早期糖尿病肾病 降糖益肾汤 中医药治疗 Early stage Diabetic Nephropathy Jiangtang Yishen Decoction TCM therapy
  • 相关文献

参考文献7

二级参考文献30

  • 1王秀问.糖尿病肾病的诊治进展[J].中国实用内科杂志,1995,15(6):361-363. 被引量:60
  • 2中华人民共和国卫生部.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002.68-74.
  • 3Mogensen CE,Schmitz A,Christensen CK. Comparative renal pathophysi-ology releva nt to IDDM and NIDDM patients[J]. Diabetes Metab Rev,1988;4(5) :453-83.
  • 4Allenherg M,Weinstein T,Li,et al. Activation of procollagenase IV bycytochalasin D and concanavalin A in cultured rat mesangial cells : linkageto cytoskeletal reorganization[ J]. J Am Soe Nephrol, 1994;4( 10) :1760-70.
  • 5Plum J, Bunten B, Nemeth R,ei al. Effects of the angiotensin II antagonist valsartan on blood pressure, proteinunia, and renal hemoodymimics inpatients with chronic renal failure and hypertension[J]. J Am Soc Neph-rol, 1998 ;9( 12) :2223-34.
  • 6America Diabetes Association.Standard of medical care in diabetes-2011[J].Diabetes Care,2011,34(Suppl 1):S11-61.
  • 7Narita T,Hosoba M,Kakei M,et al.Increased urinary excretions ofimmunoglobulin g,ceruloplasmin,and transferrin predict developmentof microalbuminuria in patients with type 2 diabetes [J].DiabetesCare,2006,29(l):142-144.
  • 8Barratt J,Topham P.Urine proteomics:the present and future ofmeasuring urinary protein components in disease [J].CMAJ,2007,177(4);361-368.
  • 9Cohen MP,Lautenslager GT,Shearman CW.Increased collagen IVexcretion in diabetes.A marker of compromised filtration function[J].Diabetes Care,2001,24(5):914-918.
  • 10RetnakaranR,Cull CA,Thome KI,et al.Risk factors for renal dys-function in type 2 diabetes:U.K.Prospective Diabetes Study 74[J].Diabetes,2006,55(6):1832-1839.

共引文献1006

同被引文献204

引证文献21

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部